Troels Yndigegn

15PUBLICATIONS
29CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Clinical chemistry (incl. diagnostics)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 03, 2026
Beta-blockers after myocardial infarction: time to change the guidelines.

Tomas Jernberg

|Sep 16, 2025
Circulating soluble LOX-1 and patient prognosis after an acute coronary syndrome.

Alexandru Schiopu, Sara Svedlund, Gayathri Narasimhan

|Jan 15, 2025
The prognostic value of global longitudinal strain in patients with myocardial infarction and preserved ejection fraction: a prespecified substudy of the REDUCE-AMI trial.

Katarina Mars, Robin Hofmann, Martin Jonsson

|Oct 18, 2024
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial.

Philip Leissner, Katarina Mars, Sophia Humphries

|Sep 01, 2024
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMI.

Katarina Mars, Sophia Humphries, Philip Leissner

|Jun 06, 2024
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals.

Ali Yari, Peter Ueda, Pia Lundman

Pageof 3

Frequent Collaborators

4 joint publications

Claes Held

4 joint publications

Annica Ravn-Fischer

4 joint publications

Joakim Alfredsson

4 joint publications

Katarina Mars